Atreca, Inc.
(NASDAQ : BCEL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
FLTFleetCor Technologies, Inc. 1.27%320.733.4%$274.16m
JCIJohnson Controls International Plc -0.96%41.351.4%$163.77m
CPRTCopart, Inc. 0.39%100.294.5%$135.84m
ETSYEtsy, Inc. 0.58%50.528.0%$121.60m
EFXEquifax, Inc. -0.61%154.012.0%$94.48m
TRUTransUnion -0.61%92.860.9%$79.59m
BAHBooz Allen Hamilton Holding Corp. -0.57%77.932.0%$65.39m
CDAYCeridian HCM Holding, Inc. -1.38%71.580.0%$61.93m
ITGartner, Inc. -0.43%160.572.4%$61.88m
PAGSPagSeguro Digital Ltd. -0.66%34.740.0%$58.34m
BRBroadridge Financial Solutions, Inc. -0.18%131.031.5%$57.28m
PRAHPRA Health Sciences, Inc. -0.38%105.312.5%$56.63m
ADPTAdaptive Biotechnologies Corp. 13.78%30.555.8%$52.75m
CHGGChegg, Inc. -0.49%42.7315.7%$47.28m
LOPEGrand Canyon Education, Inc. -1.68%91.992.0%$46.18m

Company Profile

Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman in June 11, 2010 and is headquartered in Redwood, CA.